Related Experiment Video
Updated: Jun 16, 2026

09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
[Progress of research on leukemia stem/progenitor cell targeting therapy]
1Department of Hematology, Zhongda Hospital, Southeast University Clinical Medical College, Nanjing 210009, Jiangsu Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|February 9, 2010
Summary
Conventional chemotherapy often fails for hematological malignancies due to leukemia stem cells. Targeting these resilient cells offers a promising strategy for a complete cure.
Area of Science:
- Hematology
- Cancer Stem Cell Biology
- Oncology
Context:
- Conventional chemotherapy is the primary treatment for hematological malignancies.
- Relapse is common in patients treated with chemotherapy.
- Leukemia stem/progenitor cells are implicated in treatment failure and relapse.
Purpose:
- To review recent advancements in therapies targeting leukemia stem/progenitor cells.
- To highlight strategies for eradicating hematological malignancies by addressing the root cause of relapse.
Summary:
- Leukemia stem/progenitor cells possess self-renewal and differentiation capabilities, making them resistant to conventional chemotherapy.
- Traditional chemotherapeutic drugs primarily affect differentiated tumor cells, leaving leukemia stem/progenitor cells largely unaffected.
- Effective eradication of hematological malignancies requires targeting the unique properties of these stem/progenitor cells.
Impact:
- Developing targeted therapies against leukemia stem/progenitor cells is crucial for achieving complete tumor eradication and long-term remission.
- Strategies include targeting surface markers, inducing differentiation, disrupting signaling pathways, and modulating the stem cell niche.
- This research paves the way for novel therapeutic approaches to cure hematological malignancies.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Lineage Commitment
Commitment is the process whereby stem cells:
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

